We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Profile Thera. | LSE:PTP | London | Ordinary Share | GB0001386225 | ORD 2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:2741B
Profile Therapeutics PLC
27 July 2004
Letter to Profile Therapeutics plc
SECTION 198 COMPANIES ACT 1985
We, The Royal Bank of Scotland Group plc, for ourselves and on behalf of:
The Royal Bank of Scotland plc
National Westminster Bank plc
and NatWest Ventures Investments Ltd
write to advise you pursuant to Section 198 of the Companies Act 1985 (the Act)
that:
1. This notification relates to the ordinary 2p share capital of Profile
Therapeutics plc.
2. The Royal Bank of Scotland Group plc, The Royal Bank of Scotland plc,
National Westminster Bank plc and NatWest Ventures Investments Ltd no
longer have a notifiable interest (within the meaning of Section 199(2) of
the Act) in shares comprised in the share capital.
Letter from Royal Bank of Scotland Group plc
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUBVVRSRRBUAR
1 Year Profile Thera. Chart |
1 Month Profile Thera. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
